ð ç« æ«éèš
- CURB-65 decision rule
- CAP empirical: outpatient amox/doxy; inpatient ceftri+azithro
- Severe CAP: + anti-MRSA / anti-Pseudo if risk
- Atypicals (Mycoplasma, Chlamydia, Legionella): macrolide / doxy / FQ
- VAP/HAP: pip-tazo + vanco
- Duration 5 days mild CAP, 7-14 severe, 7-14 HAP/VAP
- Aspiration: anaerobic coverage (amox-clav, clinda)